News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
139 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32275)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Policy
Galmed Granted ‘Preferred Technological Enterprise’ Status
The grant of the status means that Galmed R&D will be subject to a reduced Israeli corporate tax rate that will range between 6%-12% on any future taxable “technological income” which includes sales, licenses and royalties from its IP protected products.
February 7, 2018
·
6 min read
Drug Development
Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial
Abeona plans to enroll a total of three patients in Cohort 1 (2E13 vg/kg) before dose-escalating to the Cohort 2 dose (5E13 vg/kg).
February 7, 2018
·
8 min read
BioMidwest
Medical College of Wisconsin Release: CAR-T Cell Immunotherapy Clinical Trial Cancer Patient in Remission; First-in-the-World Cancer Treatment Shows Promise
Bret C., 52, of Appleton, Wis., is the first patient to participate in this novel clinical trial.
February 7, 2018
·
2 min read
Business
Advanced Proteome Therapeutics and ImmunoBiochem Corporation Enter Into a Collaboration and Option Agreement
The companies will evaluate the prospect of combining ImmunoBiochem’s proprietary antibody and APC’s site-selective conjugation technology to produce ADCs with superior properties, targeting triple-negative breast cancer.
February 7, 2018
·
4 min read
Novo Nordisk A/S: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons on 5 February 2018
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
February 7, 2018
·
1 min read
Bio NC
Monarch Medical Technologies Announces Self-Service Analytics, An Expansion of the EndoTool Analytics Offering
Monarch Medical Technologies today announced the launch of Self-Service Analytics, an extension of EndoTool Analytics.
February 7, 2018
·
2 min read
Sinovac Holds 2017 Annual General Meeting of Shareholders
Sinovac Biotech announced today that it held its 2017 Annual General Meeting of Shareholders on Tuesday, February 6, 2018 in Beijing, PRC.
February 7, 2018
·
2 min read
Abbott’s App for FreeStyle Libre System Now Available in Europe for Both iPhone and Android
Abbott announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones2.
February 7, 2018
·
5 min read
Policy
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
The Company received the renewed GMP certificate evidencing compliance on January 31, 2018.
February 7, 2018
·
3 min read
Drug Development
Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine
The results show markedly higher blood plasma concentrations when betahistine administered intranasally rather than orally.
February 7, 2018
·
5 min read
Previous
9 of 14
Next